These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2356284)

  • 1. Characteristics of the binding of labeled fluoromisonidazole in cells in vitro.
    Rasey JS; Nelson NJ; Chin L; Evans ML; Grunbaum Z
    Radiat Res; 1990 Jun; 122(3):301-8. PubMed ID: 2356284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Barajas RF; Ambady P; Link J; Krohn KA; Raslan A; Mallak N; Woltjer R; Muldoon L; Neuwelt EA
    Neurooncol Pract; 2022 May; 9(3):246-250. PubMed ID: 35601969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and
    Huang S; Michalek JE; Reardon DA; Wen PY; Floyd JR; Fox PT; Clarke GD; Jerabek PA; Schmainda KM; Muzi M; Hyun H; Lee EQ; Brenner AJ
    Sci Rep; 2021 Apr; 11(1):7632. PubMed ID: 33828310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research.
    Doctor A; Seifert V; Ullrich M; Hauser S; Pietzsch J
    Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32993034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Hypoxia Imaging Using
    Hirata K; Yamaguchi S; Shiga T; Kuge Y; Tamaki N
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31344848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma.
    McGowan DR; Skwarski M; Bradley KM; Campo L; Fenwick JD; Gleeson FV; Green M; Horne A; Maughan TS; McCole MG; Mohammed S; Muschel RJ; Ng SM; Panakis N; Prevo R; Strauss VY; Stuart R; Tacconi EMC; Vallis KA; McKenna WG; Macpherson RE; Higgins GS
    Eur J Cancer; 2019 May; 113():87-95. PubMed ID: 30991262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
    Masaki Y; Shimizu Y; Yoshioka T; Nishijima KI; Zhao S; Higashino K; Numata Y; Tamaki N; Kuge Y
    Ann Nucl Med; 2017 Oct; 31(8):596-604. PubMed ID: 28695498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia imaging and radiotherapy: bridging the resolution gap.
    Grimes DR; Warren DR; Warren S
    Br J Radiol; 2017 Aug; 90(1076):20160939. PubMed ID: 28540739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
    Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
    PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
    He S; Wang M; Yang Z; Zhang J; Zhang Y; Luo J; Zhang Y
    PLoS One; 2016; 11(7):e0159916. PubMed ID: 27467716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
    Gerstner ER; Zhang Z; Fink JR; Muzi M; Hanna L; Greco E; Prah M; Schmainda KM; Mintz A; Kostakoglu L; Eikman EA; Ellingson BM; Ratai EM; Sorensen AG; Barboriak DP; Mankoff DA;
    Clin Cancer Res; 2016 Oct; 22(20):5079-5086. PubMed ID: 27185374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory study of volumetric analysis for assessing tumor response with (18)F-FAZA PET/CT in patients with advanced non-small-cell lung cancer (NSCLC).
    Kerner GS; Bollineni VR; Hiltermann TJ; Sijtsema NM; Fischer A; Bongaerts AH; Pruim J; Groen HJ
    EJNMMI Res; 2016 Dec; 6(1):33. PubMed ID: 27090118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-fluoromisonidazole positron emission tomography can predict pathological necrosis of brain tumors.
    Toyonaga T; Hirata K; Yamaguchi S; Hatanaka KC; Yuzawa S; Manabe O; Kobayashi K; Watanabe S; Shiga T; Terasaka S; Kobayashi H; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1469-76. PubMed ID: 26841941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accumulation mechanism of the hypoxia imaging probe "FMISO" by imaging mass spectrometry: possible involvement of low-molecular metabolites.
    Masaki Y; Shimizu Y; Yoshioka T; Tanaka Y; Nishijima K; Zhao S; Higashino K; Sakamoto S; Numata Y; Yamaguchi Y; Tamaki N; Kuge Y
    Sci Rep; 2015 Nov; 5():16802. PubMed ID: 26582591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference Regions.
    Muzi M; Peterson LM; O'Sullivan JN; Fink JR; Rajendran JG; McLaughlin LJ; Muzi JP; Mankoff DA; Krohn KA
    J Nucl Med; 2015 Aug; 56(8):1223-8. PubMed ID: 26112020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of hypoxia in non-small-cell lung cancer.
    Yip C; Blower PJ; Goh V; Landau DB; Cook GJ
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):956-76. PubMed ID: 25701238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of FMISO-PET for glioma analysis.
    Kobayashi H; Hirata K; Yamaguchi S; Terasaka S; Shiga T; Houkin K
    Neurol Med Chir (Tokyo); 2013; 53(11):773-8. PubMed ID: 24172591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
    Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors.
    Busk M; Toustrup K; Sørensen BS; Alsner J; Horsman MR; Jakobsen S; Overgaard J
    BMC Cancer; 2011 Feb; 11():63. PubMed ID: 21306648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of biological aggressiveness assessed by 11C-methionine PET and hypoxic burden assessed by 18F-fluoromisonidazole PET in newly diagnosed glioblastoma.
    Kawai N; Maeda Y; Kudomi N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):441-50. PubMed ID: 21072512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.